Join the Pain group to help and get support from people like you.
Pain News (Page 7)
Iroko Pharmaceuticals Receives FDA Approval for Tivorbex
PHILADELPHIA, FEBRUARY 24, 2014 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug A...
FDA Medwatch Alert: Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing
ISSUE: FDA is recommending health care professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 milligrams (mg) of acetaminophen per...
FDA Approves Zohydro ER, an Extended-Release, Single-Entity Hydrocodone Product
October 25, 2013 – The U.S. Food and Drug Administration today approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough to require daily,...
Iroko Pharmaceuticals Receives FDA Approval for Zorvolex
Philadelphia, Pennsylvania, October 18, 2013 - Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S....
FDA Medwatch Alert: Duragesic (fentanyl) Patches: Drug Safety Communication - Packaging Changes to Minimize Risk of Accidental Exposure
[Posted 09/23/2013] ISSUE: FDA is requiring color changes to the writing on Duragesic (fentanyl) pain patches so they can be seen more easily. FDA continues to learn of deaths from accidental...
FDA Medwatch Alert: Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
ISSUE: Qualitest, a subsidiary of Endo Health Solutions, issued a voluntary nationwide recall for 101 lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg. Bottles from the...
FDA Medwatch Alert: Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Watson Laboratories): Recall - Potential for Oversized and Superpotent Tablets
ISSUE: Watson Laboratories, Inc. notified the public of a voluntary nationwide recall for two lots of Hydrocodone Bitartrate and APAP Tablets, USP 10 mg/500 mg (Lot Numbers 519406A and 521759A, both...
FDA Medwatch Alert: Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
ISSUE: Today, Qualitest, a subsidiary of Endo Health Solutions,issued a voluntary, nationwide retail level recall for one lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg. ...
FDA Approves Mallinckrodt's Exalgo (hydromorphone HCl) Extended-Release Tablets 32 mg (CII) for Opioid-Tolerant Patients with Moderate-to-Severe Chronic Pain
ST. LOUIS--(BUSINESS WIRE)--Aug 27, 2012 - The U.S. Food and Drug Administration (FDA) has notified Mallinckrodt, the pharmaceuticals business of Covidien, that it has approved a 32 mg tablet...
FDA Medwatch Alert: Hospira Hydromorphone Hydrochloride Injection 2 MG/ML, 1 mL fill in 2.5 mL Carpuject: Recall- May Contain More Than The Intended Fill Volume
Issue: Hospira and FDA notified healthcare professional of a nationwide voluntraty recall of one lot of Hydromorphone Injection, USP, 2 mg/mL, (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1312-30,...
FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient
ISSUE: FDA is warning consumers that Reumofan Plus, marketed as a natural dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not...
FDA Medwatch Alert: Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume
ISSUE: Hospira, Inc. notified healthcare professionals of a recall of one lot of Hydromorphone Hydrochloride Injection 1 MG/ML, due to reports of a single Carpuject containing more than the 1 mL...
FDA Medwatch Alert: Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall - May Contain More Than Intended Fill Volume
ISSUE: Customer report of two Carpujects syringes containing more than the 1 mL labeled fill volume. Opioid pain medications such as morphine have life-threatening consequences if overdosed. Those...
Insys Therapeutics Announces FDA Approval of Subsys Fentanyl Sublingual Spray
PHOENIX, Jan 5, 2012 - INSYS Therapeutics announces the US Food and Drug Administration approval of its branded breakthrough cancer pain medication, Subsys fentanyl sublingual spray. SUBSYS is a...
Pacira Pharmaceuticals, Inc. Announces U.S. FDA Approval of Exparel For Postsurgical Pain Management
PARSIPPANY, N.J., Oct. 31, 2011 /PRNewswire via COMTEX/ – Pacira Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA) has approved Exparel (bupivacaine liposome...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Pain, Back Pain, Fibromyalgia, Headache, Muscle Pain, Neuralgia, Neck Pain, Chronic Myofascial Pain, Nocturnal Leg Cramps, Reflex Sympathetic Dystrophy Syndrome, Breakthrough Pain
Related drug support groups
tramadol, gabapentin, ibuprofen, oxycodone, Tylenol, hydrocodone, naproxen, acetaminophen, meloxicam, view more... amitriptyline, aspirin, Percocet, hydroxyzine, Norco, pregabalin, methadone, duloxetine, diclofenac, OxyContin, Vicodin, codeine, cyclobenzaprine, Aleve, Celebrex, fentanyl, Advil, Voltaren, morphine, clonidine, Paracetamol Teva, nortriptyline, buprenorphine, Butrans, Paracetamol, Dilaudid, Motrin, cannabis, Tylenol PM, Toradol, indomethacin, Lortab, Ultram, Vistaril, acetaminophen / hydrocodone, Roxicodone, ketamine, Arthritis Pain, Atarax, ketorolac, Percocet 10/325, Nucynta, hydromorphone